22 September 2025
Roche's Giredestrant Boosts Progression-Free Survival in ER-Positive Breast Cancer
The evERA study shows giredestrant plus everolimus improves progression-free survival in ER-positive breast cancer, with no new safety concerns. Data to be presented at a medical meeting.
